Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL646715 | 1.00 | CNR2 (0.63) | CNR2 | |
| SCHEMBL10709155 | 1.00 | CNR2 (0.63) | CNR2 | |
| SCHEMBL29825458 | 0.83 | CNR2 (0.70) | CNR2 | |
| SCHEMBL649517 | 0.83 | CNR2 (0.70) | CNR2 | |
| SCHEMBL15396893 | 0.83 | CNR2 (0.70) | CNR2 | |
| SCHEMBL31055753 | 0.83 | CNR2 (0.70) | CNR2 | |
| SCHEMBL1129539 | 0.83 | CNR2 (0.70) | CNR2 | |
| SCHEMBL648778 | 0.83 | CNR2 (0.70) | CNR2 | |
| SCHEMBL19327397 | 0.81 | CNR2 (0.77) | CNR2 | |
| SCHEMBL30256039 | 0.81 | CNR2 (0.77) | CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4267111-A | Process for preparing β-(3-exo-hydroxy-endo-2,3-dimethyl-2-norbornyl)-propionic acid .delta. | FRITZSCHE DODGE & OLCOTT INC. (US) | 1981-05-12 | — | — | US | claimed |
| EP-2726447-B1 | PROCESS FOR THE PREPARATION OF BETA-SANTALOL | FIRMENICH & CIE (CH) | 2015-08-12 | — | — | EP | disclosed |
| EP-2726447-B1 | PROCESS FOR THE PREPARATION OF BETA-SANTALOL | FIRMENICH & CIE (CH) | 2015-08-12 | — | — | EP | disclosed |
| US-9056826-B2 | Process for the preparation of beta-santalol | FIRMENICH SA (CH) | 2015-06-16 | — | — | US | disclosed |
| US-9056826-B2 | Process for the preparation of beta-santalol | FIRMENICH SA (CH) | 2015-06-16 | — | — | US | disclosed |
| US-9056826-B2 | Process for the preparation of beta-santalol | FIRMENICH SA (CH) | 2015-06-16 | — | — | US | disclosed |
| EP-2675776-B1 | INTERMEDIATES FOR THE PREPARATION OF BETA-SANTALOL | FIRMENICH & CIE (CH) | 2015-04-08 | — | — | EP | disclosed |
| US-8822733-B2 | Intermediates for the preparation of beta-santalol | FIRMENICH SA (CH) | 2014-09-02 | — | — | US | disclosed |
| US-8822733-B2 | Intermediates for the preparation of beta-santalol | FIRMENICH SA (CH) | 2014-09-02 | — | — | US | disclosed |
| US-8822733-B2 | Intermediates for the preparation of beta-santalol | FIRMENICH SA (CH) | 2014-09-02 | — | — | US | disclosed |
| US-20110118497-A1 | PROCESS FOR THE PREPARATION OF BETA-SANTALOL AND DERIVATIVES THEREOF | FIRMENICH SA | 2011-05-19 | — | — | US | disclosed |
| US-7902393-B2 | Process for the preparation of β-santalol and derivatives thereof | FIRMENICH SA (CH) | 2011-03-08 | — | — | US | disclosed |
| EP-2282985-A1 | PROCESS FOR THE PREPARATION OF BETA-SANTALOL AND DERIVATIVES THEREOF | Firmenich SA (CH) | 2011-02-16 | — | — | EP | disclosed |
| US-20110028750-A1 | PROCESS FOR THE PREPARATION OF BETA-SANTALOL AND DERIVATIVES THEREOF | FIRMENICH SA (CH) | 2011-02-03 | — | — | US | disclosed |
| WO-2009141781-A1 | PROCESS FOR THE PREPARATION OF BETA-SANTALOL AND DERIVATIVES THEREOF | FIRMENICH SA (CH) | 2009-11-26 | — | — | WO | disclosed |
| EP-0148399-B1 | POLYCYCLIC ALCOHOL, PROCESS FOR ITS PREPARATION, ITS USE AS SMELLING INGREDIENT, AND COMPOSITION CONTAINING IT | FIRMENICH SA (CH) | 1988-01-13 | — | — | EP | disclosed |
| EP-0148399-A2 | Polycyclic alcohol, process for its preparation, its use as smelling ingredient, and composition containing it | FIRMENICH SA (CH) | 1985-07-17 | — | — | EP | disclosed |
| US-4267111-A | Process for preparing β-(3-exo-hydroxy-endo-2,3-dimethyl-2-norbornyl)-propionic acid .delta. | FRITZSCHE DODGE & OLCOTT INC. (US) | 1981-05-12 | — | — | US | disclosed |
| US-4223167-A | Processes for preparing β-santalol, β-santalene dihydro-β-santalol and related compounds | FRITZSCHE DODGE & OLCOTT INC. (US) | 1980-09-16 | — | — | US | disclosed |
| EP-0010213-A2 | Bicyclo-compounds, processes for their preparation and their application | BASF Aktiengesellschaft (DE) | 1980-04-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110028750-A1 | PROCESS FOR THE PREPARATION OF BETA-SANTALOL AND DERIVATIVES THEREOF | SQLE, EBP, CYP17A1 | CNR2 937/4885 |
| US-20110118497-A1 | PROCESS FOR THE PREPARATION OF BETA-SANTALOL AND DERIVATIVES THEREOF | EBP, C9, DEGS1 | CNR2 1537/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.